ArticleMolecular cancer research : MCR2016

Targeting RRM2 and Mutant BRAF Is a Novel Combinatorial Strategy for Melanoma.

Nail Fatkhutdinov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.